🇺🇸 FDA
Pipeline program

Sildenafil citrate

A1481244

Approved small_molecule terminated

Quick answer

Sildenafil citrate for Pulmonary Arterial Hypertension is a Approved program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).

Program details

Company
Pfizer
Indication
Pulmonary Arterial Hypertension
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials